Gujrat leads pharma sector with record 183 new plants
Ahmedabad: Gujarat has further cemented its position as India’s pharmaceutical powerhouse with the state’s Food and Drug Control Administration (FDCA) approving 183 new allopathic drug manufacturing facilities in FY 2024-25,…
Doctor not liable for prescribing costly drug: HC
Cuttack: Orissa high court has ruled that a doctor should not be held criminally liable for prescribing a particular drug of any pharmaceutical company for treatment of a disease like…
878 Tramadol capsules being smuggled in Scorpio seized, three arrested
Bansur: Narayanpur police station has busted a drug smuggling racket. Police have recovered 878 Tramadol capsules from a Scorpio. Three people have been arrested in this case. According to police station…
Doctor not criminally liable for prescribing costly drug: Orissa High Court
CUTTACK: Orissa high court has ruled that a doctor should not be held criminally liable for prescribing a particular drug of any pharmaceutical company for treatment of a disease like…
Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1
Mumbai: Suven Pharmaceuticals Limited, a contract development and manufacturing organization (CDMO), has announced that it has received final approval from the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers,…
Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion
India’s largest diagnostics service provider, Dr Lal PathLabs (DLPL), on Friday reported an 81.4 per cent year-on-year (Y-o-Y) increase in consolidated net profit for the March quarter of financial year…
Lupin-led price cut slashes cost of key TB drug pretomanid by 25%
Global access to tuberculosis (TB) medicine pretomanid received a shot in the arm, as its price saw a 25 per cent drop, thanks to a third licensed partner, Mumbai-based drugmaker…
250% rally in one year! Multibagger pharma stock jumps despite stock market crash
Stock Marke: With 250% rally in one year the Multibagger pharma stock gained further on the BSE on Friday, during the intraday trades despite stock market crash. The Sudarshan Pharma…
Laurus Labs Q4 net surges to Rs 234 cr. on higher CDMO revenue
Drugmaker Laurus Labs reported consolidated net profit for the March quarter surged to ₹233.87 crore from ₹75.32 crore a year earlier on a 19% increase in the revenue. Revenue from…
Relief for pharma cos as Delhi HC says cough syrup ban applies prospectively
New Delhi: In a relief to pharma companies, including Glenmark Pharmaceuticals and Zuventus Healthcare, the Delhi High Court on Thursday held that the government’s April 15 notification that prohibited the…